# Octave Specialty Group share price today (Octave Specialty Group, Inc., OSG)

> Octave Specialty Group, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. OSG · Financials · Insurance - Specialty · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/osg

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $5.01 (−39.0% in a year)
- P/BV: 0.3× (lower than 69% of the last 1 year)
- Revenue (Jun 2026): $83.0 M (+51.0% on a year ago)
- Profit (Jun 2026): −$12.2 M
- Net margin: −14.6% (+118.1 points on a year ago)
- ROE: −7%, FY25

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Octave Specialty Group share price today? Octave Specialty Group, Inc.'s share price was $5.01 at the close on 3 November 2026. That is 3.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between $4 and $10, and at that close it sat 19% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 1 year the share price moved −29% while the S&P 500 moved +21%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Octave Specialty Group pay? Octave Specialty Group, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Octave Specialty Group on? Octave Specialty Group is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Octave Specialty Group profitable? Octave Specialty Group, Inc. posted a net loss of $12.2 M in the Jun 2026 quarter. The full FY25 year was a loss of $259 M. That loss is 14.6% of the quarter's revenue. The same quarter a year earlier lost $73.0 M. 10 of the last 12 reported quarters were loss-making. ## How much revenue does Octave Specialty Group make, and is it growing? Octave Specialty Group, Inc. reported $83.0 M of income in the Jun 2026 quarter, +51.0% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown 0.2% a year on average. The last full year, FY25, came in at $251 M. The last four reported quarters add to $321 M. The quarterly figures for FY22 do not add up to the full-year total on file, so those quarters are left out of the charts and sums. FY25 revenue was $251 M, +4.3% on the year before. Recent pace: the last four quarters grew +26.9% on average, against 0.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +24.4%, against +18.2% a year over the last 8 quarters (accelerating). ## How much does Octave Specialty Group keep from what it earns? Octave Specialty Group, Inc.'s net margin was −14.6% in the Jun 2026 quarter, 118.1 percentage points higher than the same quarter a year ago. Across 5 years it has been between −231.0% and 976.0%. The latest quarter is within that range. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Octave Specialty Group's loans have gone bad? Octave Specialty Group, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Octave Specialty Group's loan book growing? Octave Specialty Group, Inc.'s revenue was $251 M in FY25, +4.3% on the year before, so the loan book is growing. The latest quarter was +51.0% on a year earlier. The net margin on that income is −14.6%, +118.1 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Octave Specialty Group's P/BV ratio, and how does it compare with its own history? Octave Specialty Group, Inc.'s P/BV is 0.3×, near the low end of its own history: it has been lower only 31% of the time. Its usual P/BV (the middle reading) is 0.4×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about −7% a year on its equity. A lender that earns less on its net worth is valued lower for each dollar of it, and that gap usually closes only if returns improve. In short: the multiple is low against its own past, so the book value trend underneath matters more than the multiple. ## Is the Octave Specialty Group business getting better or worse? Octave Specialty Group, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 9 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Octave Specialty Group earn on its equity and assets? Octave Specialty Group, Inc. earned a return on equity of −24% in FY25. Its lowest yearly reading on file was −47% in FY24. On its assets, every $100 earned about −$0.47, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why: the ROE chart shows the move, but the deposit-cost and bad-loan details behind it are not in our data. ## Does Octave Specialty Group have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Octave Specialty Group shareholding pattern? 3.2% of Octave Specialty Group, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Octave Specialty Group from balance-sheet trouble? For Octave Specialty Group, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Octave Specialty Group rank in its industry? 46.5 out of 100, rank 11 of 17 in Insurance - Specialty, with 55% of the evidence available. Octave Specialty Group, Inc. scores 46.5 out of 100 against the 17 companies it is compared with in Insurance - Specialty, ranking 11. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 23.4 + 5.3 + 9.8 + 8 = 46.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Octave Specialty Group compared with? Octave Specialty Group ranks 11 of 17 Insurance - Specialty companies on the 4-Factor Sector Score, with 46.5 out of 100. 1. [AXIS Capital Holdings Limited](https://www.sectoralpha.in/us/stocks/axs) AXS · turning · Most evidence points up · 76% evidence 68.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Income 9.1% · Profit 24.6% · 71% evidence Capital efficiency 16.7/25 · ROA 2.2% · ROE 16% · GNPA n/a · 68% evidence Valuation 14.9/20 · P/BV 1.22× · P/BV÷ROE 0.08 · 70% evidence Relative strength 15.2/20 · Lead over its industry 7.1% · Lead over S&P 500 -1.8% · 1 year 6.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.2 + 16.7 + 14.9 + 15.2 = 68 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [First American Financial Corporation](https://www.sectoralpha.in/us/stocks/faf) FAF · basing · Most evidence points up · 80% evidence 67.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Income 14.2% · Profit 52.1% · 81% evidence Capital efficiency 17.4/25 · ROA 4.5% · ROE 15.7% · GNPA n/a · 68% evidence Valuation 16.0/20 · P/BV 1.15× · P/BV÷ROE 0.07 · 70% evidence Relative strength 5.6/20 · Lead over its industry 1.1% · Lead over S&P 500 -7% · 1 year 4.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 28.7 + 17.4 + 16 + 5.6 = 67.7 · What this means: Earnings are strong; relative strength in its sector is 1.1% and the one-year return is 4.2%. 3. [Ryan Specialty Holdings, Inc.](https://www.sectoralpha.in/us/stocks/ryan) RYAN · turning · Most evidence points up · 76% evidence 65.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.9/35 · Income 14.9% · Profit 73.7% · 71% evidence Capital efficiency 15.3/25 · ROA 3.2% · ROE 13.1% · GNPA n/a · 68% evidence Valuation 3.0/20 · P/BV 4.81× · P/BV÷ROE 0.37 · 70% evidence Relative strength 19.6/20 · Lead over its industry 14% · Lead over S&P 500 3.7% · 1 year -21.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 27.9 + 15.3 + 3 + 19.6 = 65.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [NMI Holdings, Inc.](https://www.sectoralpha.in/us/stocks/nmih) NMIH · quiet · Evidence leans up · 76% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Income 7.5% · Profit 4.5% · 71% evidence Capital efficiency 19.7/25 · ROA 8.5% · ROE 15.2% · GNPA n/a · 68% evidence Valuation 15.3/20 · P/BV 1.15× · P/BV÷ROE 0.08 · 70% evidence Relative strength 15.2/20 · Lead over its industry 11.9% · Lead over S&P 500 2.9% · 1 year 18.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.8 + 19.7 + 15.3 + 15.2 = 63 · What this means: Relative strength against the index is 2.9%, and revenue and profit growth are weak. 5. [Essent Group Ltd.](https://www.sectoralpha.in/us/stocks/esnt) ESNT · turning · Evidence leans up · 76% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Income 4.3% · Profit -4.6% · 71% evidence Capital efficiency 16.3/25 · ROA 7.1% · ROE 12% · GNPA n/a · 68% evidence Valuation 14.8/20 · P/BV 1.05× · P/BV÷ROE 0.09 · 70% evidence Relative strength 15.9/20 · Lead over its industry 11.1% · Lead over S&P 500 2.2% · 1 year 10.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 13.2 + 16.3 + 14.8 + 15.9 = 60.2 · What this means: Relative strength against the index is 2.2%, and revenue and profit growth are weak. 6. [Enact Holdings, Inc.](https://www.sectoralpha.in/us/stocks/act) ACT · quiet · Evidence leans up · 76% evidence 57.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.6/35 · Income 2.4% · Profit 0.7% · 71% evidence Capital efficiency 17.1/25 · ROA 8.1% · ROE 12.5% · GNPA n/a · 68% evidence Valuation 13.2/20 · P/BV 1.18× · P/BV÷ROE 0.1 · 70% evidence Relative strength 14.7/20 · Lead over its industry 13.1% · Lead over S&P 500 4.4% · 1 year 28.4% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.6 + 17.1 + 13.2 + 14.7 = 57.6 · What this means: Relative strength against the index is 4.4%, and revenue and profit growth are weak. 7. [Investors Title Company](https://www.sectoralpha.in/us/stocks/itic) ITIC · quiet · Evidence leans up · 76% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Income 8.1% · Profit 28.1% · 71% evidence Capital efficiency 14.4/25 · ROA 5.3% · ROE 9% · GNPA n/a · 68% evidence Valuation 7.0/20 · P/BV 1.8× · P/BV÷ROE 0.2 · 70% evidence Relative strength 9.4/20 · Lead over its industry 6.2% · Lead over S&P 500 -2.2% · 1 year -3.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 25.1 + 14.4 + 7 + 9.4 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Radian Group Inc.](https://www.sectoralpha.in/us/stocks/rdn) RDN · basing · Evidence leans up · 76% evidence 55.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.6/35 · Income 37.5% · Profit -8.7% · 71% evidence Capital efficiency 15.4/25 · ROA 5.8% · ROE 10.8% · GNPA n/a · 68% evidence Valuation 13.4/20 · P/BV 1.04× · P/BV÷ROE 0.1 · 70% evidence Relative strength 11.9/20 · Lead over its industry 5.3% · Lead over S&P 500 -3.2% · 1 year 2.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 14.6 + 15.4 + 13.4 + 11.9 = 55.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [MGIC Investment Corporation](https://www.sectoralpha.in/us/stocks/mtg) MTG · basing · Evidence leans up · 76% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.5/35 · Income -1.8% · Profit -7.2% · 71% evidence Capital efficiency 17.8/25 · ROA 8.3% · ROE 13% · GNPA n/a · 68% evidence Valuation 13.6/20 · P/BV 1.19× · P/BV÷ROE 0.09 · 70% evidence Relative strength 11.2/20 · Lead over its industry 6.3% · Lead over S&P 500 -2.3% · 1 year 2.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 9.5 + 17.8 + 13.6 + 11.2 = 52.1 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [Fidelity National Financial, Inc.](https://www.sectoralpha.in/us/stocks/fnf) FNF · basing · Evidence leans down · 76% evidence 47.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Income 12.6% · Profit -22.1% · 71% evidence Capital efficiency 13.8/25 · ROA 1.4% · ROE 14.5% · GNPA n/a · 68% evidence Valuation 11.9/20 · P/BV 1.44× · P/BV÷ROE 0.1 · 70% evidence Relative strength 2.4/20 · Lead over its industry -12.9% · Lead over S&P 500 -20.6% · 1 year -27.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19 + 13.8 + 11.9 + 2.4 = 47.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. Octave Specialty Group, Inc. this page OSG · turning · Too little evidence to rank firmly · 55% evidence 46.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Income 24.4% · Profit n/a · 45% evidence Capital efficiency 5.3/25 · ROA 0.3% · ROE -1.1% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 0.28× · P/BV÷ROE n/a · 10% evidence Relative strength 8.0/20 · Lead over its industry -8.8% · Lead over S&P 500 -17.4% · 1 year -40.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.4 + 5.3 + 9.8 + 8 = 46.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 12. [AMERISAFE, Inc.](https://www.sectoralpha.in/us/stocks/amsf) AMSF · basing · Evidence leans down · 76% evidence 38.4 out of 100 Growth Capital Valuation Relative
13. [Employers Holdings, Inc.](https://www.sectoralpha.in/us/stocks/eig) EIG · quiet · Evidence leans down · 76% evidence 36.1 out of 100 Growth Capital Valuation Relative
14. [Assured Guaranty Ltd.](https://www.sectoralpha.in/us/stocks/ago) AGO · basing · Most evidence points down · 76% evidence 31.9 out of 100 Growth Capital Valuation Relative
15. [Tiptree Inc.](https://www.sectoralpha.in/us/stocks/tipt) TIPT · turning · Too little evidence to rank firmly · 46% evidence 46.2 out of 100 Growth Capital Valuation Relative
16. [MBIA Inc.](https://www.sectoralpha.in/us/stocks/mbi) MBI · basing · Too little evidence to rank firmly · 45% evidence 39.5 out of 100 Growth Capital Valuation Relative
17. James River Group Holdings, Inc. JRVR · basing · Too little evidence to rank firmly · 47% evidence 29.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Insurance - Specialty](https://www.sectoralpha.in/us/sectors/insurance-specialty), all 17 compared on one page. ## Which companies are close to Octave Specialty Group in size? Octave Specialty Group is the 16th largest of 16 Insurance - Specialty companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Assured Guaranty, Employers Holdings, Inc., Tiptree Inc., Investors Title Company, AMERISAFE, Inc. and MBIA Inc. It is the smallest. ### Insurance - Specialty companies close in size

1. [Assured Guaranty Ltd.](https://www.sectoralpha.in/us/stocks/ago) $3.1 billion
2. [Employers Holdings, Inc.](https://www.sectoralpha.in/us/stocks/eig) $830 million
3. [Tiptree Inc.](https://www.sectoralpha.in/us/stocks/tipt) $644 million
4. [Investors Title Company](https://www.sectoralpha.in/us/stocks/itic) $504 million
5. [AMERISAFE, Inc.](https://www.sectoralpha.in/us/stocks/amsf) $379 million
6. [MBIA Inc.](https://www.sectoralpha.in/us/stocks/mbi) $226 million
7. Octave Specialty Group, Inc. $226 million

[All 16 Insurance - Specialty companies, largest first](https://www.sectoralpha.in/us/sectors/insurance-specialty#all-companies)

### Companies close in size in other industries

1. [AstroNova, Inc.](https://www.sectoralpha.in/us/stocks/alot) $227 million · Computer Hardware
2. [Ohio Valley Banc Corp.](https://www.sectoralpha.in/us/stocks/ovbc) $227 million · Banks - Regional
3. Octave Specialty Group, Inc. $227 million
4. [Digi Power X Inc.](https://www.sectoralpha.in/us/stocks/dgxx) $227 million · Utilities - Independent Power Producers
5. [HireQuest, Inc.](https://www.sectoralpha.in/us/stocks/hqi) $227 million · Staffing & Employment Services

## What else do people ask about Octave Specialty Group? ### What were Octave Specialty Group's latest quarterly results? Octave Specialty Group, Inc. reported total income of $83.0 M and a net loss of $12.2 M for the Jun 2026 quarter. Earnings per share were −$0.33. The net margin was −14.6%, 118.1 percentage points higher than a year earlier (as of 3 November 2026). ### What is Octave Specialty Group's market cap? Octave Specialty Group, Inc.'s market capitalisation is $226 M at a stock price of $5.01. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Octave Specialty Group performing? Octave Specialty Group, Inc.'s latest readings are below. Over the past 13 weeks it has done better than the S&P 500, for 1 week running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Octave Specialty Group's stock price go up? This page does not forecast Octave Specialty Group, Inc.'s stock price. What it shows instead: the stock price is $5.01. Its P/BV of 0.3× is higher than 31% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Octave Specialty Group in its business cycle? Octave Specialty Group, Inc.'s FY25 net margin was −103.1%, against a 5-year range of −231.0% to 976.0%: the low end of its own range, which is often where recoveries start. The latest quarter was −14.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Octave Specialty Group story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Octave Specialty Group a stock worth studying right now? What the numbers show: Octave Specialty Group, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.